MDACC Study Summary 2005-0576

Study Summary
No. 2005-0576:.......Laboratory; Unspecified......Alyssa Rieber......General Oncology

Study Summary Title



Study Summary Number:	2005-0576

Study Title:	LBJ Patient History Database - Serum/DNA Bank

Physician

New Patient Referral



Name:	Alyssa Rieber	Patients Call:	800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)

Dept:	General Oncology	Referring MD Call:	800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)

Phone:	713-563-0746 Contact us about clinical trials

General Information



Disease Group:	Laboratory Unspecified	Supported By:	N/A

Phase of Study:	N/A	Return Visit:	N/A

Treatment Agents:	None	Home Care:	N/A

Treatment Loc:	Independent Multicenter Arrangements

Estimated Length of Stay in Houston:	N/A


Description/ Intervention:	The goal of this research study is to collect and store patients' clinical information. This will help researchers learn more about the causes of cancer and ways to treat and prevent cancer. Researchers may use what is learned to develop new medicines, new methods of treatment, and new ways of preventing cancer.

Study Objectives / Outcomes

1. To prospectively collect standardized core epidemiologic data on patients who are being seen at LBJ Hospital with a confirmed or suspected diagnosis of cancer or with a risk of cancer (e.g., elevated PSA, BPH).
2. To collect information yearly on recurrence and survival as well as the proportion of patients who remain in follow-up in the clinic after initial cancer care.
3. To develop a DNA/serum bank that will enable us to pursue molecular epidemiologic and translational studies in this unique patient population.
4. To provide research infrastructure for our medical oncology fellows for the development of research projects that would expand their knowledge of underserved populations and the potential barriers to research in this group of patients.
5. To document the patients' symptoms at presentation using the M. D. Anderson Symptom Inventory (MDASI) or, for male urology patients only, the Expanded Prostate Cancer Index Composite (EPIC).

Study Status Information



Study Activation / Registration Date:	03/14/2006

IRB Review and Approval Date:	03/14/2006

Study Type:	Other

Recruitment Status:	Open

Projected Accrual:	2250

Enrollment Eligibility

If you do not meet the enrollment eligibility, there may be other treatment options for you. Please Contact the Referral Office for more information.

Inclusion Criteria:

1) Patients who are being seen at LBJ Hospital with a confirmed or suspected diagnosis of cancer or with a risk of cancer (e.g., elevated PSA, BPH).

2) Patients aged 18 or older.

3) Agree to complete interviewer administered questionnaires with or without a blood and/or urine sample.

4) Must understand English or Spanish unless a qualified translator and translated consent form are available for another language.

Exclusion Criteria:

1) Blood transfusions in the last 4 months (for blood samples only).

2) Patients aged 17 years or younger.

Links

Registration Number: Not Applicable Clinical Trial